Valuing Valuation in Pharma R&D »

Trust in early pharmaceutical pipeline product valuation has all but evaporated. And yet views of value are increasingly important to the improvement in effectiveness of R&D that is so sorely needed in the pharmaceuticals sector. Where does this paradox come from and what can be done about it? By Andrew Chadwick and Tom Parke Why […]